Private company
Prospekta
Nootropic drug
Prospekta is a nootropic drug reported to act on the S100 proteins. It was developed by the company Materia Medica and approved in Russia for the treatment of ADHD in 2022.2 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
See how the biggest companies compare on our leaderboards
Prospekta is a nootropic drug reported to act on the S100 proteins. It was developed by the company Materia Medica and approved in Russia for the treatment of ADHD in 2022.2
Links
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataProspekta on Wikidata
- 2WikipediaProspekta on Wikipedia